X0508 4 2025-12-22 0 0001787518 Nukkleus Inc. NUKK 0002045096 Kotaieva Anastasiia C/O ABOUDI LEGAL GROUP PLLC 745 FIFTH AVENUE, SUITE 500 NEW YORK NY 10151 0 0 0 1 See Remarks below 0 Common Stock, $0.0001 par value per share 2025-12-22 4 S 0 30000 4.4146 D 1331197 I X Group Fund of Funds Limited Partnership Common Stock, $0.0001 par value per share 2025-12-23 4 S 0 70000 4.5726 D 1261197 I X Group Fund of Funds Limited Partnership Common Stock, $0.0001 par value per share 2025-12-24 4 S 0 55604 4.4894 D 1205593 I X Group Fund of Funds Limited Partnership Common Stock, $0.0001 par value per share 2025-12-26 4 S 0 55604 4.2629 D 1149989 I X Group Fund of Funds Limited Partnership The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.49 to $4.415, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Anastasiia Kotaieva is the owner of X Group Fund of Funds Limited Partnership. The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.905 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.47 to $4.23, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.48 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Former director and 10% shareholder /s/ Anastasiia Kotaieva 2025-12-29